Dow’s New Excipient Is Designed for Hot-Melt Extrusion
Oct 15, 2015
By Pharmaceutical Technology Editors
At CPhI Worldwide 2015, The Dow Chemical Company announced the global commercial availability of AFFINISOL HPMC HME, a new generation of cellulosic polymer for drug solubilization. The polymer is designed for use by pharmaceutical companies looking to enhance the solubilization and inhibit the recrystallization of APIs in hot-melt extrusion (HME) formulations. The product’s ability to overcome solubilization of poorly soluble APIs addresses one of the main challenges facing the pharmaceutical industry today and may help pharmaceutical companies to enhance the commercial viability of pipeline APIs.
